Who owns ETERNA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Eterna Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Eterna Therapeutics stock

Who bought or sold ETERNA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Cypress Point Wealth Management 94k $169k 0% Dec 2023
 View chart
Naviter Wealth 79k $141k -1% Dec 2023
 View chart
Sippican Capital Adivsors 54k $97k 92% Dec 2023
 View chart
CI Private Wealth 50k $90k -2% Dec 2023
 View chart
Vanguard Group 26k $47k 5% Dec 2023
 View chart
Geode Capital Management 23k $51k 64% Sep 2023
 View chart
BlackRock 17k $36k -7% Sep 2023
 View chart
Baldwin Brothers 8.5k $15k -10% Dec 2023
 View chart
Tower Research Capital 4.6k $10k -8% Sep 2023
 View chart
A. Montag and Associates 70.00 $126.000000 0% Dec 2023
 View chart
Morgan Stanley 50.00 $109.000000 0% Sep 2023
 View chart
Royal Bank of Canada 31.00 $0 0% Dec 2023
 View chart
Wells Fargo & Company 28.00 $49.999600 8% Dec 2023
 View chart
Group One Trading 19.00 $43.000800 0% Sep 2023
 View chart
Citigroup 15.00 $27.000000 0% Dec 2023
 View chart
Jpmorgan Chase & Co 14.00 $24.999800 0% Dec 2023
 View chart
Aspire Private Capital 10.00 $17.000000 0% Dec 2023
 View chart
Qube Research & Technologies 4.00 $9.000000 100% Sep 2023
 View chart
FMR 1.00 $2.000000 0% Sep 2023
 View chart

Who sold out of Eterna Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
UBS Group Sep 2023 105.00 $229.005000
Nbc Securities Sep 2023 10.00 $0